Effect of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) on Lipid Particles in Type 2 Diabetes Mellitus (T2DM)

被引：0
|
作者：
Jones, Michael R.
Ford, Daniel M.
Baz-Hecht, Merav
Tao, Ben
Truitt, Kenneth E.
Chou, Hubert S.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1161-P
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [41] Mechanistic disease progression analysis indicates that pioglitazone prevents the progression of type 2 diabetes mellitus (T2DM)
    De Winter, W
    Dejongh, J
    Urquhart, R
    Moules, I
    Eckland, D
    Danhof, M
    [J]. DIABETES, 2004, 53 : A122 - A122
  • [42] Colesevelam as an Add-On Treatment for Control of Dyslipidemia and Hyperglycemia in Type 2 Diabetes
    Sandhu, Supna
    Moosavi, Mandana
    Golmohammadi, Kamran
    Francis, Gordon A.
    [J]. CANADIAN JOURNAL OF DIABETES, 2016, 40 (02) : 112 - 114
  • [43] Addition of Alogliptin vs Uptitration of Pioglitazone Dose in Type 2 Diabetes Mellitus (T2DM) Patients on Metformin Plus Pioglitazone Therapy
    Bosi, Emanuele
    Ellis, Graham
    Moneuse, Patrick
    Wilson, Craig
    Fleck, Penny
    [J]. DIABETES, 2010, 59 : A148 - A148
  • [44] THE PREVALENCE OF MICROALBUMINURIA IN CHILDREN WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Yafi, Michael
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 : A250 - A250
  • [45] Regional effects of type 2 diabetes mellitus (T2DM) on neurodegeneration
    Moran, C.
    Phan, T. G.
    Beare, R. J.
    Chen, J.
    Blizzard, L.
    Venn, A.
    Greenaway, T.
    Munch, G.
    Forbes, J.
    Pearson, S.
    Srikanth, V
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 20 - 20
  • [46] Gut microbiota influence in type 2 diabetes mellitus (T2DM)
    A. L. Cunningham
    J. W. Stephens
    D. A. Harris
    [J]. Gut Pathogens, 13
  • [47] Pregnancy outcomes in women with Type 2 diabetes mellitus (T2DM)
    Tan, Z.
    Pang, W. H.
    Todd, D.
    Halliday, M.
    Gill, F.
    Rhoads, M.
    Sathiskumar, P.
    Gallagher, A.
    de Chazal, R.
    Lawrence, I. G.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [48] Gut microbiota influence in type 2 diabetes mellitus (T2DM)
    Cunningham, A. L.
    Stephens, J. W.
    Harris, D. A.
    [J]. GUT PATHOGENS, 2021, 13 (01)
  • [49] Effect of pioglitazone on splanchnic glucose uptake, endogenous glucose production, and hepatic fat content in type 2 diabetes mellitus (T2DM)
    Bajaj, M
    Suraamornkul, S
    Pratipanawatr, T
    Hardies, LJ
    Glass, L
    Miyazaki, Y
    Pratipanawatr, W
    Cersosimo, E
    Defronzo, R
    [J]. DIABETES, 2002, 51 : A35 - A35
  • [50] Effect of pioglitazone on liver fat content, abdominal fat distribution, and insulin sensitivity in patients with type 2 diabetes mellitus (T2DM)
    Miyazaki, Y
    Hardies, LJ
    Wajcberg, E
    Glass, L
    Triplitt, C
    Bajaj, M
    Cersosimo, E
    Mandarino, LJ
    Defronzo, RA
    [J]. DIABETES, 2002, 51 : A69 - A69
12345